Patents Assigned to Laboratoires Chauvin-Blache
  • Patent number: 4929635
    Abstract: The invention relates to compounds of the formula ##STR1## These compounds may be used in therapeutics for the treatment of acne, psoriasis, disorders of keratinization, in certain forms of cancer and as healing agents, particularly in the ocular field.
    Type: Grant
    Filed: December 5, 1985
    Date of Patent: May 29, 1990
    Assignee: Laboratoires Chauvin-Blache
    Inventors: Claude Coquelet, Samia Roussillon, Daniel Sincholle, Claude Bonne, Alain Alazet
  • Patent number: 4866088
    Abstract: Buffered opthalmic solutions of indomethacin.
    Type: Grant
    Filed: April 20, 1987
    Date of Patent: September 12, 1989
    Assignee: Laboratoires Chauvin-Blache
    Inventors: Florence Maurin, Claude Coquelet, Tournoux A. Alain
  • Patent number: 4785008
    Abstract: The subject of the invention is N-substituted 2-aminothiazoles of formula ##STR1## in which: X is a C--H group or a nitrogen atom,R.sub.1 and R.sub.2 are, independently of each other, a hydrogen atom, a halogen atom or an alkyl, alkoxy, alkylthio, alkenyloxy, cycloalkyl, trifluoromethyl, nitro, amino, (C.sub.1 -C.sub.6 alkyl)amino or di(C.sub.1 -C.sub.6 alkyl)-amino radical, andR.sub.3 is a hydrogen atom, a --CH.sub.2 --OH group or a --COOR.sub.4 group, R.sub.4 being a hydrogen atom or an alkyl group,and also the pharmaceutically acceptable salts thereof.These compounds have an anti-inflammatory and antiallergic activity and can be used in therapy, especially in the ocular field.
    Type: Grant
    Filed: April 24, 1986
    Date of Patent: November 15, 1988
    Assignee: Laboratoires Chauvin-Blache
    Inventors: Claude Coquelet, Daniel Sincholle, Claude Bonne, Alain Alazet
  • Patent number: 4665085
    Abstract: Compounds having the formula (I) wherein R.sub.1 and R.sub.2 are a hydrogen atom, an alkyl group or a hydroxy group, or else R.sub.1 and R.sub.2 form together a bivalent ethylene or trimethylene radical; R.sub.3 is a halogen atom, an alkyl group, an alkoxy group, a mono- or polyhydroxylated alkyl group, an amino group, a mono- or di-alkyl amino group, an acetamido or sulfonamido group; R.sub.1 is a hydroxy group, a mono- or polyhydroxylated alkyl group, an amino group, a mono- or dialkyl amino group, an acetamido or sulfonamido group; R.sub.4 being in the position 3, 4 or 5 and A is a bridge having from 1 to 3 links selected among the groups having the formula (II), --NH--,--N.dbd.--O-- and --S--. R.sub.5 represents an hydrogen atom, an alkyl group, a hydroxy group or an alkoxy group as well as the addition salts thereof with pharmaceutically acceptable acids. Said compound may be used in therapeutical treatment as antihypertensive agents, particularly in the ocular field.
    Type: Grant
    Filed: March 12, 1985
    Date of Patent: May 12, 1987
    Assignee: Laboratoires Chauvin-Blache
    Inventors: Claude Coquelet, Elisabeth Battais, Claude Bonne, Daniel Sincholle
  • Patent number: 4407812
    Abstract: This invention relates to a therapeutic composition comprising, as active ingredient, a compound of the formula (I) ##STR1## in which R is hydrogen or an ether or ester residue, or a therapeutically acceptable acid addition salt thereof.This composition is applicable to the treatment and the prevention of thromboses.
    Type: Grant
    Filed: January 21, 1981
    Date of Patent: October 4, 1983
    Assignee: Laboratoires Chauvin-Blache
    Inventors: Claude Bonne, Claude Coquelet, Daniel Sincholle
  • Patent number: 4190661
    Abstract: This invention relates to compounds having the formula: ##STR1## in which: R represents a C.sub.1-6 alkyl radical or a C.sub.1-6 alkenyl radical; A represents an indazol-2,3- or 4,5- or 6,7-diyl radical, which indazoldiyl radical may be substituted on the nitrogen atoms at 1- or 2-position with C.sub.1-6 alkyl or phenyl-(C.sub.1-6) alkyl radicals, and their salts with pharmaceutically acceptable bases.Said compounds are therapeutically useful as antibacterial agents.
    Type: Grant
    Filed: May 16, 1978
    Date of Patent: February 26, 1980
    Assignee: Laboratoires Chauvin-Blache
    Inventors: P. Le Hao Dong, Claude Coquelet